1st Quarter 2017
Key topics in this quarter’s edition include:
- Axicabtagene ciloleucel for the treatment of non-Hodgkin lymphoma
- Midostaurin for the treatment of acute myelogenous leukemia and aggressive systemic mastocytosis
- Ribociclib for the treatment of breast cancer
- Tisagenlecleucel-T for the treatment of acute lymphoblastic leukemia
Top